Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: clinical and sample considerations
about
Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeSequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes.Genome-wide identification of genes probably relevant to the adaptation of schizothoracins (Teleostei: Cypriniformes) to the uplift of the Qinghai-Tibet Plateau.Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.Tumor protein D52 represents a negative regulator of ATM protein levels.Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?Gene set enrichment analysis of the NF-κB/Snail/YY1/RKIP circuitry in multiple myeloma.Retracted: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer CellsKnockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma.hABCF3, a TPD52L2 interacting partner, enhances the proliferation of human liver cancer cell lines in vitro.The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.Retracted: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation In VitroIncreased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
P2860
Q26770333-0ECDCB79-7912-447D-B927-C1AA4B02FF46Q30505291-91E3B841-B292-40CD-9692-22EE560C826CQ33582361-30222AD7-8E2C-42D1-8536-43071F6BF37DQ35802220-226942C0-EB0F-4A82-B59C-8C7646FE532AQ37420061-1C421B9C-AF8E-4C5B-A25F-973EBE224739Q38209599-6E679EB0-4B2A-4B9B-85B3-DB3C3A7D0E41Q38480261-70FFA5E0-2F1F-4D6C-A8AE-EB2498031943Q38915723-18C3BEF5-C4A8-4624-87F1-81FC0FC40268Q38952658-8B5274A8-2932-486C-84CD-F456FCD459EBQ39093886-9C5B406D-BC7C-4209-BAE6-E163947F0A4AQ39145269-BA237322-3B4F-4C1D-AA2F-F20AD6473EE3Q42156701-BD49FD4F-2A12-49FE-9AE6-BC93BCDC5182Q47132562-86C32DF3-2931-4C99-96F9-AC562E35E36CQ48188689-6BF2DD32-3A09-4CA9-BE7B-B9A042E930CDQ54441612-0A26A178-1618-47A8-9C5E-D18FEC054E23
P2860
Expression of tumor protein D52-like genes in childhood leukemia at diagnosis: clinical and sample considerations
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of tumor protein D5 ...... ical and sample considerations
@ast
Expression of tumor protein D5 ...... ical and sample considerations
@en
Expression of tumor protein D5 ...... ical and sample considerations
@nl
type
label
Expression of tumor protein D5 ...... ical and sample considerations
@ast
Expression of tumor protein D5 ...... ical and sample considerations
@en
Expression of tumor protein D5 ...... ical and sample considerations
@nl
prefLabel
Expression of tumor protein D5 ...... ical and sample considerations
@ast
Expression of tumor protein D5 ...... ical and sample considerations
@en
Expression of tumor protein D5 ...... ical and sample considerations
@nl
P2093
P1433
P1476
Expression of tumor protein D5 ...... ical and sample considerations
@en
P2093
Draga Barbaric
Karen Byth
Luciano Dalla-Pozza
P304
P356
10.1016/J.LEUKRES.2006.03.009
P407
P577
2006-04-18T00:00:00Z